onr:"swepub:oai:DiVA.org:oru-94785"
Search: onr:"swepub:oai:DiVA.org:oru-94785" > The Cost-Effectiven...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Jendle, Johan,1963-Örebro universitet,Institutionen för medicinska vetenskaper (author)
The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes : a Health Economic Analysis in Sweden
- Article/chapterEnglish2021
Publisher, publication year, extent ...
- 2021-10-01
- Springer,2021
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:oru-94785
- https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-94785URI
- https://doi.org/10.1007/s13300-021-01157-0DOI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- Funding agency:Medtronic International Trading Sàrl, Geneva, Switzerland
- INTRODUCTION: Swedish National Diabetes Registry data show a correlation of improved glycemic control in people with type 1 diabetes (T1D) with increased use of diabetes technologies over the past 25 years. However, novel technologies are often associated with a high initial outlay. The aim of the present study was to evaluate the long-term cost-effectiveness of the advanced hybrid closed-loop (AHCL) MiniMed 780G system versus intermittently scanned continuous glucose monitoring (isCGM) plus self-injection of multiple daily insulin (MDI) or continuous subcutaneous insulin infusion (CSII) in people with T1D in Sweden.METHODS: Outcomes were projected over patients' lifetimes using the IQVIA CORE Diabetes Model (v9.0). Clinical data, including changes in glycated hemoglobin (HbA1c) and hypoglycemia rates, were sourced from observational studies and a randomized crossover trial. Modeled patients were assumed to receive the treatments for their lifetimes, with HbA1c kept constant following the application of treatment effects. Costs were accounted from a societal perspective and expressed in Swedish krona (SEK). Utilities and days off work estimates were taken from published sources.RESULTS: The MiniMed 780G system was associated with an improvement in life expectancy of 0.16 years and an improvement in quality-adjusted life expectancy of 1.95 quality-adjusted life years (QALYs) versus isCGM plus MDI or CSII. These clinical benefits were due to a reduced incidence and a delayed time to onset of diabetes-related complications. Combined costs were estimated to be SEK 727,408 (EUR 72,741) higher with MiniMed 780G, with treatment costs partially offset by direct cost savings from the avoidance of diabetes-related complications and indirect cost savings from the avoidance of lost workplace productivity. The MiniMed 780G system was associated with an incremental cost-effectiveness ratio of SEK 373,700 per QALY gained.CONCLUSIONS: Based on a willingness-to-pay threshold of SEK 500,000 per QALY gained, the MiniMed 780G system was projected to be cost-effective versus isCGM plus MDI or CSII for the treatment of T1D in Sweden.
Subject headings and genre
- MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Endokrinologi och diabetes hsv//swe
- MEDICAL AND HEALTH SCIENCES Clinical Medicine Endocrinology and Diabetes hsv//eng
- Advanced hybrid closed-loop
- Cost-effectiveness
- Sweden
- Type 1 diabetes
Added entries (persons, corporate bodies, meetings, titles ...)
- Buompensiere, M. I.Medtronic International Trading Sàrl, Tolochenaz, Switzerland (author)
- Holm, A. L.Medtronic Denmark, Copenhagen, Denmark (author)
- de Portu, S.Medtronic International Trading Sàrl, Tolochenaz, Switzerland (author)
- Malkin, S. J. P.Ossian Health Economics and Communications, Basel, Switzerland (author)
- Cohen, O.Medtronic International Trading Sàrl, Tolochenaz, Switzerland (author)
- Örebro universitetInstitutionen för medicinska vetenskaper (creator_code:org_t)
Related titles
- In:Diabetes Therapy: Springer12:11, s. 2977-29911869-69531869-6961
Internet link
Find in a library
- Diabetes Therapy (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Jendle, Johan, 1 ...
- Buompensiere, M. ...
- Holm, A. L.
- de Portu, S.
- Malkin, S. J. P.
- Cohen, O.
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Endocrinology an ...
- Articles in the publication
- Diabetes Therapy
- By the university
- Örebro University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
